Human Amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Manuelpillai, Ursula ^a   Lourensz, Dinushka ^a,c   Vaghjiani, Vijesh ^a   Tchongue, Jorge ^a,c   Lacey, Derek ^b   Tee, Jing Yang ^a   Murthi, Padma ^b,d   Chan, James ^a   Hodge, Alexander ^a,c   Sievert, William ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Gastroenterology and Hepatology Unit   (Australia)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CD206 GENE; CELL ISOLATION; CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; GENE; GENE EXPRESSION; HUMAN; HUMAN AMNIOTIC EPITHELIAL CELL TRANSPLANTATION; HUMAN CELL; IL 10 GENE; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; STELLATE CELL; T LYMPHOCYTE; YM1 GENE;

AMNION; ANIMALS; ANTIBODY FORMATION; CARBON TETRACHLORIDE; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MACROPHAGE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84862260797     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038631     Document Type: Article

References (42)

1. Friedman SL, (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669.
2. Friedman LS, (2010) Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc 121: 192-204; discussion 205.
3. Hanje AJ, Patel T, (2007) Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol 4: 266-276.
4. Gilchrist ES, Plevris JN, (2010) Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl 16: 118-129.
5. Tsai PC, Fu TW, Chen YM, Ko TL, Chen TH, et al. (2009) The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl 15: 484-495.
6. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, et al. (2004) Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 40: 1304-1311.
7. Fang B, Shi M, Liao L, Yang S, Liu Y, et al. (2004) Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78: 83-88.
8. Couto BG, Goldenberg RC, da Fonseca LM, Thomas J, Gutfilen B, et al. (2011) Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study. Liver Int 31: 391-400.
9. Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, et al. (2009) Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 21: 1199-1205.
10. Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR, et al. (2008) Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 103: 1952-1958.
11. Levicar N, Pai M, Habib NA, Tait P, Jiao LR, et al. (2008) Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif 41: 115-125.
12. Stutchfield BM, Forbes SJ, Wigmore SJ, (2010) Prospects for stem cell transplantation in the treatment of hepatic disease. Liver Transpl 16: 827-836.
13. Manuelpillai U, Tchongue J, Lourensz D, Vaghjiani V, Samuel CS, et al. (2010) Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl-treated mice. Cell Transplant 19: 1157-1168.
14. Manuelpillai U, Moodley Y, Borlongan CV, Parolini O, (2011) Amniotic membrane and amniotic cells: Potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta 32: S320-325.
15. Ilancheran S, Moodley Y, Manuelpillai U, (2009) Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta 30: 2-10.
16. Parolini O, Alviano F, Bagnara GP, Bilic G, Buhring HJ, et al. (2008) Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26: 300-311.
17. Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, van Griensven M, et al. (2007) Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13: 1173-1183.
18. Ramachandran P, Iredale JP, (2009) Reversibility of liver fibrosis. Ann Hepatol 8: 283-291.
19. Karlmark KR, Wasmuth HE, Trautwein C, Tacke F, (2008) Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev Gastroenterol Hepatol 2: 233-242.
20. Miki T, Marongiu F, Dorko K, Ellis EC, Strom SC, (2007) Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol Chapter 1: Unit 1E 3.
21. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, et al. (2007) Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 77: 577-588.
22. Pratama G, Vaghjiani V, Tee JY, Liu YH, Tan C, et al. (2011) Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications. PLoS One 6: e26136.
23. Patella S PD, Tchongue J, de Kretser DM, Sievert W, (2006) Follistatin attenuates early liver fibrosis: effects of hepatic stellate cell activation and hepatocyte apoptosis. American Journal of Physiology Gastrointestinal and Liver Physiology 290: G137-144.
24. Takashima S, Ise H, Zhao P, Akaike T, Nikaido T, (2004) Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct Funct 29: 73-84.
25. Wasmuth HE, Tacke F, Trautwein C, (2010) Chemokines in liver inflammation and fibrosis. Semin Liver Dis 30: 215-225.
26. Kisseleva T, Brenner DA, (2007) Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 22: S73-78.
27. Wynn TA, Barron L, (2010) Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 30: 245-257.
28. Kolios G, Valatas V, Kouroumalis E, (2006) Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol 12: 7413-7420.
29. Aoyama T, Inokuchi S, Brenner DA, Seki E, (2010) CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice. Hepatology 52: 1390-1400.
30. Heymann F, Trautwein C, Tacke F, (2009) Monocytes and macrophages as cellular targets in liver fibrosis. Inflamm Allergy Drug Targets 8: 307-318.
31. Murray PJ, Wynn TA, (2011) Protective and pathogenic functions of macrophage subsets. Nature reviews Immunology 11: 723-737.
32. Yang X, Song L, Wu N, Liu Z, Xue S, et al. (2010) An experimental study on intracerebroventricular transplantation of human amniotic epithelial cells in a rat model of Parkinson's disease. Neurol Res 32: 1054-1059.
33. Moodley Y, Ilancheran S, Samuel C, Vaghjiani V, Atienza D, et al. (2010) Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am J Respir Crit Care Med 182: 643-651.
34. Cargnoni A, Gibelli L, Tosini A, Signoroni PB, Nassuato C, et al. (2009) Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 18: 405-422.
35. Liu T, Wu J, Huang Q, Hou Y, Jiang Z, et al. (2008) Human amniotic epithelial cells ameliorate behavioral dysfunction and reduce infarct size in the rat middle cerebral artery occlusion model. Shock 29: 603-611.
36. Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, et al. (2009) CCR2 promotes hepatic fibrosis in mice. Hepatology 50: 185-197.
37. Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, et al. (2011) Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 61: 416-26.
38. Karlmark KR, Zimmermann HW, Roderburg C, Gassler N, Wasmuth HE, et al. (2010) The fractalkine receptor CXCR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology 52: 1769-1782.
39. Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon-Walker TT, et al. (2011) Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 53: 2003-2015.
40. Madala SK, Pesce JT, Ramalingam TR, Wilson MS, Minnicozzi S, et al. (2010) Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis. Journal of Immunology 184: 3955-3963.
41. Dayan V, Yannarelli G, Billia F, Filomeno P, Wang XH, et al. (2011) Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Res Cardiol 106: 1299-1310.
42. Busch SA, Hamilton JA, Horn KP, Cuascut FX, Cutrone R, et al. (2011) Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. J Neurosci 31: 944-953.